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Letters to the Editordiameter of the cannula is the key factor
in generating the pressure drop, rather
than the shape of the tip. In addition,
relative to axillary artery cannulation,
a larger size of cannula can be used for
innominate artery cannulation, which
may decrease blood damage, especially
during periods of high flow rate.
The main comment of Ji and col-
leagues is that during antegrade
cerebral perfusion (ACP), when the
innominate artery is used as the can-
nulation site, blood flow distribution
may depend on there resistance of 2 ar-
teries, the right axillary artery and the
right common carotid artery. Thus any
decrease or increase in the resistance
of the right axillary artery could result
in malperfusion of the brain. Com-
pared with direct axillary artery can-
nulation technique, the perfusion
pressure for the common carotid ar-
tery can be monitored by direct right
radical artery cannulation. Therefore,
ACP can be adjusted by flow rate
combined with perfusion pressure.
Usually a flow rate of 8 to 10 mL $
kg1 $ min1 is used for ACP, while
the perfusion pressure may be main-
tained between 40 and 50 mm Hg.
When the perfusion pressure is too
low, the flow rate can be increased to
avoid underperfusion to the brain.
When the perfusion pressure is too
high, such as higher than 70 mm Hg,
the flow rate can be decreased. We
therefore believe that this technique
may be better than ACP with a fixed
flow rate. Our clinical results have
also confirmed that ACP with innom-
inate artery cannulation is an accept-
able brain protective method during
arch surgery.1 We also do agree that
transcranial Doppler ultrasonography
combined with near-infrared spectros-
copy is a more accurate means of
monitoring brain perfusion state.
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To the Editor:
I read with interest the recently pub-
lished study of McKellar and col-
leagues regarding the effectiveness of
dabigatran etexilate for thrombopro-
phylaxis of mechanical heart valves.1
In this animal study, McKellar and col-
leagues1 used a model of heterotopic
aortic valve replacement in which, as
described previously, the valve within
the modified valved conduit remains
open continuously throughout the car-
diac cycle.2 Surprisingly, this very im-
portant information regarding the
valve function after this extra-
anatomic valved conduit placement is
missing fromtheir recent studyasapos-
sible major limitation.1
Historically, successful aortic valve
replacement is considered the implan-
tation of a mechanical or tissue valve
in the aortic positionwith the prosthetic
valve leaflets remaining open only dur-
ing systole and closed during diastole. I
believe that this historic definition of
successful aortic valve replacement
has neverbeenchallengedand certainly
has never changed, so I have the follow-
ing questions: (1) Did the authors
make a modification in their model
leading to a periodic, synchronous to
cardiac cycle opening and closing of
the mechanical valve? (2) If no modifi-
cation to their previously published
model has been made, how can they
translate their findings into clinical aor-
tic valve replacement practice in light
of the extra-anatomic position of the
mechanical prosthetic valve and the
fact that this valve function is com-
pletely different from that considered
clinically successful?of Thoracic and Cardiovascular SurgerMihalis E. Argiriou, MD
Evangelismos Hospital
Athens, GreeceReferences
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We appreciate Argiriou’s comments.
The heterotopic porcine model
described in our study is useful for
screening antithrombotic therapy for
mechanical valves.1-3 The procedure
is less costly in terms of time and
equipment than heterotopic valve
replacement, and mortality among
experimental animals is relatively low.
Rapid, robust thrombus formation
is important in the swine model
because of somatic growth and the
considerable expense of housing
animals for long periods. It is true that
the tilting discs of the bileaflet valves
do not open and close normally;
however, we actually consider this an
advantage of the model in that lack of
leaflet washing might actually be
expected to increase thrombogenicity
of the valve. Indeed, we previously
compared thrombus formation on
mechanical valve prostheses in the
heterotopic aortic and orthotopic
mitral positions, and at 30 days,
thrombus formation was greater on
the heterotopically placed valves.4
Thus any therapies that reduce or elim-
inate thrombus formation in this hetero-
topic model should be effective in an
orthotopic model.
Stephen H. McKellar, MD, MSc
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Division of Cardiovascular Surgery
Mayo Clinic College of Medicine
Rochester, Minny c Volume 142, Number 6 1591
Letters to the EditorReferences
1. McKellar SH, Abel S, Camp CL, Suri RM,
Ereth MH, Schaff HV. Effectiveness of dabigatran
etexilate for thromboprophylaxis of mechanical
heart valves. J Thorac Cardiovasc Surg. 2011;
141:1410-6.
2. Thompson JL, Hamner CE, Potter DD, Lewin M,
Sundt TM, Schaff HV. Melagatran for thrombopro-1592 The Journal of Thoracic andphylaxis after mechanical valve implantation: re-
sults in a heterotopic porcine model. J Thorac
Cardiovasc Surg. 2007;134:359-65.
3. McKellar SH, Thompson JL 3rd, Garcia-
Rinaldi RF, Macdonald RJ, Sundt TM 3rd,
Schaff HV. Short- and long-term efficacy of aspi-
rin and clopidogrel for thromboprophylaxis of
mechanical heart valve: an in vivo study inCardiovascular Surgery c December 20swine. J Thorac Cardiovasc Surg. 2008;136:
908-14.
4. McKellar SH, Thompson JL, Schaff HV. A model
of heterotopic aortic valve replacement for studying
thromboembolism prophylaxis in mechanical valve
prostheses. J Surg Res. 2007;141:1-6.
doi:10.1016/j.jtcvs.2011.09.00111
